Eyeworld

The LENSAR Laser System – fs 3D (LLS-fs 3D) is intended for use in patients undergoing cataract surgery for removal of the crystalline lens. Intended uses in cataract surgery include anterior capsulotomy, laser phacofragmentation, and the creation of full and partial thickness single-plane and multi-plane arc cuts/incisions in the cornea, each of which may be performed either individually or consecutively during the same procedure. Laser Capsulotomy, laser phacofragmentation and/or corneal incisions surgery is contraindicated in patients: who are of pediatric age, whose pupils will not dilate or remain dilated to a diameter greater than that of the intended treatment and for capsulotomies and/or laser phacofragmentation with intended diameters of less than 4 mm or greater than 7 mm, who have existing corneal implants, who have previous corneal incisions that might provide a potential space into which the gas produced by the procedure can escape, who have conditions that would cause inadequate clearance between the intended capsulotomy cut and the corneal endothelium, such as: hypotony, uncontrolled glaucoma, who have corneal disease or pathology that precludes transmission of light at the laser wavelength or causes distortion of laser light, such as: corneal opacities, residual, recurrent, active ocular or uncontrolled eyelid disease or any corneal abnormalities (including endothelial dystrophy, guttata, recurrent corneal erosion, etc.) in the eye to be treated, ophthalmoscopic signs of keratoconus (or keratoconus suspect) in the eye to be treated, a history of severe dry eye that has not responded to therapy, a history of herpes zoster or herpes simplex keratitis. Potential contraindications are not limited to those included in the list. WARNING: The safety and effectiveness of this laser have NOT been established in patients with diabetic retinopathy, a history of treated glaucoma, or prior intraocular surgery. * These features have not been evaluated by the FDA at the time of this publication. 1. Data on le. LENSAR, Inc. © 2014 LENSAR, Inc. All rights reserved. LENSAR and the LENSAR logo are registered trademarks and Augmented Reality is a trademark of LENSAR, Inc. 50-00075-000 Rev. A 05/14 ALWAYS THINKING AHEAD The LENSAR ® Laser System was specically designed with the needs of cataract surgeons in mind. Automated features and thoughtful ergonomics allow for seamless integration without added time. Superior imaging, iris registration, * and precise laser delivery contribute to a safe treatment with maximized outcomes. Auto cataract grading * and the ability to place laser pulses within 500 μm 1 of the posterior capsule result in a reduction in phaco energy up to 100%. 1 And full connectivity of pre- and post-op diagnostics ensures optimization and reproducibility like never before. Visit www.LENSAR.com to nd out what else we've thought of that makes LENSAR the intelligent choice for cataract surgery, for today and for the future. THINK ENERGY REDUCTION CONNECTED EFFICIENCY PATIENT SAFETY LENSAR is the ONLY femtosecond cataract laser with iris registration and auto cataract grading * LENSAR is the ONL Y femtos is the ONL LY femtosecond cataract laser with iris registration and auto cataract grading Y femtosecond cataract laser with iris registration and auto cataract grading Y femtosecond cataract laser with iris registration and auto cataract grading Y femtosecond cataract laser with iris registration and auto cataract grading * Y femtosecond cataract laser with iris registration and auto cataract grading allow for seamless integration without added time. Superior imaging, iris registration, ® The LENSAR allow for seamless integration without added time. Superior imaging, iris registration, Laser System was specically designed with the needs of cataract surgeons in mind. Automated features and thoughtful ergonomic ® allow for seamless integration without added time. Superior imaging, iris registration, Laser System was specically designed with the needs of cataract surgeons in mind. Automated features and thoughtful ergonomic THINK * allow for seamless integration without added time. Superior imaging, iris registration, Laser System was specically designed with the needs of cataract surgeons in mind. Automated features and thoughtful ergonomic THINK Laser System was specically designed with the needs of cataract surgeons in mind. Automated features and thoughtful ergonomic THINK s Laser System was specically designed with the needs of cataract surgeons in mind. Automated features and thoughtful ergonomic that of the intended treatment and for capsulotomies and/or laser phacofragmentation with intended diameters of less than 4 mm , laser phaco Laser Capsulotomy y, laser phacofragmentation and/or cor same procedure. phacofragmentation, and the creation of full and par The LENSAR Laser System – fs 3D (LLS-fs 3D) is intended for use in patients undergoing cataract surger for today and for the future. .L www.LE Visit phaco energy up to 100%. maximized outcomes. Auto cataract grading that of the intended treatment and for capsulotomies and/or laser phacofragmentation with intended diameters of less than 4 mm y is contraindicated in patients: who are of pediatric age, whose pupils will not dilate or remain dilated to a diameter greate neal incisions surger , laser phacofragmentation and/or cor tial thickness single-plane and multi-plane arc cuts/incisions in the cor phacofragmentation, and the creation of full and par The LENSAR Laser System – fs 3D (LLS-fs 3D) is intended for use in patients undergoing cataract surger for today and for the future. to nd out what else we've thought of that makes LENSAR R.com NSAR .LE And full connectivity of pre- and post-op diagnostics ensures optimization and reproducibility like never before. 1 phaco energy up to 100%. maximized outcomes. Auto cataract grading or greater than 7 mm, who have existing cor that of the intended treatment and for capsulotomies and/or laser phacofragmentation with intended diameters of less than 4 mm y is contraindicated in patients: who are of pediatric age, whose pupils will not dilate or remain dilated to a diameter greate med either individually or consecutively during the for nea, each of which may be per tial thickness single-plane and multi-plane arc cuts/incisions in the cor y include anterior capsulotomy ystalline lens. Intended uses in cataract surger y for removal of the cr The LENSAR Laser System – fs 3D (LLS-fs 3D) is intended for use in patients undergoing cataract surger to nd out what else we've thought of that makes LENSAR And full connectivity of pre- and post-op diagnostics ensures optimization and reproducibility like never before. and the ability to place laser pulses within 500 μm * maximized outcomes. Auto cataract grading neal implants, who have or greater than 7 mm, who have existing cor r than y is contraindicated in patients: who are of pediatric age, whose pupils will not dilate or remain dilated to a diameter greate med either individually or consecutively during the , laser clude anterior capsulotomy y, laser the intelligent choice for cataract surgery to nd out what else we've thought of that makes LENSAR And full connectivity of pre- and post-op diagnostics ensures optimization and reproducibility like never before. of the posterior capsule result in a reduction in 1 and the ability to place laser pulses within 500 μm the intelligent choice for cataract surgery And full connectivity of pre- and post-op diagnostics ensures optimization and reproducibility like never before. of the posterior capsule result in a reduction in , t surgery y, And full connectivity of pre- and post-op diagnostics ensures optimization and reproducibility like never before. of the posterior capsule result in a reduction in © 2014 LENSAR, Inc. All rights reser 1. Data on le. LENSAR, Inc. * These features have not been evaluated by the FDA at the time of this publication. ARNING: The safety and effectiveness of this laser have NOT been established in patients with diabetic retinopathy W Potential contraindications are not limited to those included in the list. simplex keratitis. the eye to be treated, ophthalmoscopic signs of keratoconus (or keratoconus suspect) in the eye to be treated, a histor neal opacities, residual, recur of laser light, such as: cor neal endothelium, such as: hypotony capsulotomy cut and the cor neal incisions that might provide a potential space into which the gas produced by the procedure can escape, who have condition previous cor that of the intended treatment and for capsulotomies and/or laser phacofragmentation with intended diameters of less than 4 mm ved. LENSAR and the LENSAR logo are registered trademarks and Augmented Reality is a trademark of LENSAR, Inc. 50-00075-000 Rev © 2014 LENSAR, Inc. All rights reser * These features have not been evaluated by the FDA at the time of this publication. ARNING: The safety and effectiveness of this laser have NOT been established in patients with diabetic retinopathy Potential contraindications are not limited to those included in the list. the eye to be treated, ophthalmoscopic signs of keratoconus (or keratoconus suspect) in the eye to be treated, a histor rent, active ocular or uncontrolled eyelid disease or any cor neal opacities, residual, recur , uncontrolled glaucoma, who have cor eal endothelium, such as: hypotony y, uncontrolled glaucoma, who have cor neal incisions that might provide a potential space into which the gas produced by the procedure can escape, who have condition that of the intended treatment and for capsulotomies and/or laser phacofragmentation with intended diameters of less than 4 mm . A 05/14 ved. LENSAR and the LENSAR logo are registered trademarks and Augmented Reality is a trademark of LENSAR, Inc. 50-00075-000 Rev . y. y of treated glaucoma, or prior intraocular surger , a histor c retinopathy y, a histor , a histor y eye that has not responded to therapy y, a histor y of severe dr the eye to be treated, ophthalmoscopic signs of keratoconus (or keratoconus suspect) in the eye to be treated, a histor , guttata, recur malities (including endothelial dystrophy y, guttata, recur neal abnor rent, active ocular or uncontrolled eyelid disease or any cor neal disease or pathology that precludes transmission of light at the laser wavelength or causes distor , uncontrolled glaucoma, who have cor s that would cause inadequate clearance between the intended neal incisions that might provide a potential space into which the gas produced by the procedure can escape, who have condition or greater than 7 mm, who have existing cor that of the intended treatment and for capsulotomies and/or laser phacofragmentation with intended diameters of less than 4 mm . A 05/14 y of herpes zoster or herpes , a histor neal erosion, etc.) in rent cor , guttata, recur tion neal disease or pathology that precludes transmission of light at the laser wavelength or causes distor s that would cause inadequate clearance between the intended neal implants, who have or greater than 7 mm, who have existing cor N KI N HI T S YS AY LWA A D A HE A G N 69-72 ION_EW June 2014-DL_Layout 1 6/3/14 12:57 PM Page 71

• Cover